Trial Details

Not Recruiting
Basic Information
Clinical ID c5029
Identifier IRCT20230801058996N5
Trial Title Safety and efficacy of placental mesenchymal stem cells-derived exosomes in severe refractory inflammatory bowel disease patients
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Intervention group: Injection of placental mesenchymal stem cells-derived exosomes: On day 1, 3 vials of exosomes (equivalent to 1011 particles or 250-300 micrograms of exosome) with an interval of 8 hours, then one vial of exosome maintenance dose daily
Interventions The percentage of patients who show adverse effects during or after exosome injection. Timepoint: From the first dose of exosome infusion until 3 months on days 7, 30, 60 and 90 after the last dose. Method of measurement: Patient statements and medical te
Participant Information
Sponsor Shahid Beheshti University of Medical Sciences
City NULL
Country/Region Elham Roshandel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL